SAT641 The Xanthine Oxidoreductase Inhibitor, Febuxostat, Protects Against Nanomaterial Inhalation-induced Endocrine, Microvascular And Reproductive Dysfunction During Gestation

Disclosure: E. Bowdridge: None. A. Dunn: None. J. Griffith: None. E. DeVallance: None. E. Kelley: None. S. Lewis: None. Maternal inhalation exposure to nano-TiO(2) during gestation impacts litter size, pup and placental mass, circulating estrogen concentration, and uterine microvascular reactivity....

Descripción completa

Detalles Bibliográficos
Autores principales: Bowdridge, Elizabeth, Dunn, Allison, Griffith, Julie, DeVallance, Evan, Kelley, Eric, Lewis, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Endocrine Disrupting Chemicals
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553873/
http://dx.doi.org/10.1210/jendso/bvad114.1080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553873/
http://dx.doi.org/10.1210/jendso/bvad114.1080

Ejemplares similares